Management

Chief Executive Officer

Mr Tristan Brittain-Dissont M.A
He is an economics graduate with extensive and varied commercial experience of the life sciences industry, having worked for blue chip pharmas, biotechs, contract research organisations, and VC-backed/UK affiliate start-ups. Following five years at Merck, Sharp and Dohme and Rhone Poulenc-Rorer, he helped establish Biogen’s first UK sales and marketing operation. Subsequent to these roles he joined Covance, the global Contract Research Organisation, managing European business development functions. This led to him co-founding in 1999 Intercern, the 3i-backed patient recruitment organisation, which he left after four years to pursue a variety of consultancy projects with CROs and start-ups. He is also Investment Manager of the SpringHill Bioventures venture capital fund.

..............................................................................................

Chief Financial Officer

Mr Cameron Denny MBA, FCCA, FCMA, MCT
A qualified Accountant with additional qualifications in Corporate Treasury, Procurement and Logistics, as well as, an MBA. He has worked in such blue chip companies as Nabisco, Nynex and Cable and Wireless, as well as, being trained in KPMG. He spent 15 years in the Telecommunications industry, which included a period with one of the largest telecommunications companies in France, Intercomm, subsequently part of UPC, Europe's largest cable communications company. Prior to joining Springhill he worked in the Public Sector. He has worked in the Middle East, the Caribbean, the USA, France and the UK. He has a degree in Biology specialising in Microbiology. He is also the CFO of Springhill Management Ltd, a private equity fund management company.